Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Rebound Pain in Inguinal Hernia Repair
NCT05172908Completed
- Sponsor
- Karaman Training and Research Hospital
- Start
- Jan 2022
- Primary completion
- Apr 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in postoperative pain (2 arms), sponsored by Karaman Training and Research Hospital. Primary endpoints: Modified Rebound Pain Score at 24 hours and Analgesic consumption at 24 hours. Started Jan 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05172908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05172908.